Aurora Cannabis Inc. advised the market of a second instance of misinformation posted on Investing.com, following an earlier denial of an acquisition report. The new article incorrectly stated that Aurora had entered into a strategic partnership with MediPharm GmbH for distribution in Germany and other EU markets.
The company categorically denied both Investing.com articles, stating it has not engaged in any such agreements or discussions with either MedLeaf Therapeutics or MediPharm GmbH. Aurora emphasized that the erroneous articles were reportedly generated 'with the support of AI' and reviewed by an editor.
Aurora confirmed it is not in possession of material non-public information and advised investors that Investing.com should not be considered a credible source for company information. The company is launching an investigation into the origin of these articles to ensure market integrity.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.